Erin Lewis, NP
Nurse Practitioner · Springfield, MONPI 1356955231
Payments from drug & device makers
Across 89 payments — averaging $18.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$561
- Novartis$170
- Johnson & Johnson$169
- E.r. Squibb & Sons, L.L.C.$136
- LEO Pharma Inc.$128
- UCB, Inc.$110
- plus $415 from 13 others
What the payments were for
- Food & beverage$1,59995%
- Education$905%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 31 | $561 |
| Novartis | 8 | $170 |
| Johnson & Johnson | 7 | $169 |
| E.r. Squibb & Sons, L.L.C. | 7 | $136 |
| LEO Pharma Inc. | 6 | $128 |
| UCB, Inc. | 5 | $110 |
| Pfizer | 6 | $94 |
| Sun Pharmaceutical Industries Inc. | 4 | $66 |
| Amgen | 3 | $54 |
| Fresenius Kabi USA, LLC | 2 | $35 |
| Lilly USA, LLC | 2 | $32 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $24 |
| Almirall LLC | 1 | $20 |
| Dermavant Sciences, Inc. | 1 | $16 |
| Incyte Corporation | 1 | $16 |
| Sanofi | 1 | $15 |
| Organon | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| Arcutis Biotherapeutics, Inc. | 1 | $13 |
How this compares
$1,689 in reported general payments places this provider in the 80th percentile of 1,898 nurse practitioner providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 21 | $142,437 |
| Dupixent PenDupilumab | 12 | $43,420 |
| Clobetasol Propionate | 143 | $4,963 |
| Fluorouracil | 20 | $2,154 |
| Desonide | 30 | $1,902 |
| Triamcinolone Acetonide | 125 | $1,113 |
| Ketoconazole | 79 | $972 |
| Betamethasone Dipropionate | 13 | $828 |
| Clindamycin Phosphate | 18 | $668 |
| Doxycycline Hyclate | 34 | $457 |
| Nystatin | 26 | $265 |
| Mupirocin | 38 | $183 |
| Ciclopirox | 13 | $170 |
| Cephalexin | 12 | $137 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Springfield
- Michelle DickensSpringfield$59K
- Sara HillSpringfield$9K
- Lisa PotthoffSpringfield$9K
- Edrie WichernSpringfield$9K
- Leslie LeeSpringfield$8K
- Aeron SheffieldChesterfield$269K
- Rachel ImperatoOsage Beach$260K
- Matthew BrunsBridgeton$126K
- Robert HafnerKansas City$47K
- Tracey CarpenterChesterfield$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.